83.22
0.22 (0.27%)
| Previous Close | 83.00 |
| Open | 83.25 |
| Volume | 1,189,516 |
| Avg. Volume (3M) | 3,348,860 |
| Market Cap | 38,020,972,544 |
| Price / Earnings (TTM) | 22.80 |
| Price / Earnings (Forward) | 17.83 |
| Price / Sales | 1.94 |
| Price / Book | 4.54 |
| 52 Weeks Range | |
| Earnings Date | 6 Feb 2025 - 20 Feb 2025 |
| TTM Dividend Yield | 0.14% |
| Profit Margin | 8.56% |
| Operating Margin (TTM) | 16.06% |
| Diluted EPS (TTM) | 3.65 |
| Quarterly Revenue Growth (YOY) | 0.90% |
| Quarterly Earnings Growth (YOY) | 25.30% |
| Total Debt/Equity (MRQ) | 126.09% |
| Current Ratio (MRQ) | 1.23 |
| Operating Cash Flow (TTM) | 2.09 B |
| Levered Free Cash Flow (TTM) | 1.82 B |
| Return on Assets (TTM) | 5.64% |
| Return on Equity (TTM) | 21.85% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Mixed | Bearish |
| Health Information Services (Global) | Mixed | Bearish | |
| Stock | GE HealthCare Technologies Inc. | Bullish | Bullish |
AIStockmoo Score
| Analyst Consensus | 1.5 |
| Insider Activity | NA |
| Price Volatility | 2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -0.5 |
| Average | 1.38 |
|
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (54% of revenue), ultrasound (18%), patient care solutions (16%), and pharmaceutical diagnostics (12%). The company’s sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 44%, 26%, 14%, and 16% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (33% of revenue), pharmaceutical diagnostics (12%), and digital solutions (6%). |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Mid Core |
| % Held by Insiders | 3.09% |
| % Held by Institutions | 83.53% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Egerton Capital (Uk) Llp | 30 Sep 2024 | 5,680,021 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 102.00 (Evercore ISI Group, 22.57%) | Buy |
| 102.00 (Stifel, 22.57%) | Buy | |
| Median | 98.00 (17.76%) | |
| Low | 74.00 (UBS, -11.08%) | Sell |
| Average | 94.00 (12.95%) | |
| Total | 4 Buy, 1 Hold, 1 Sell | |
| Avg. Price @ Call | 89.84 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Wells Fargo | 31 Oct 2024 | 96.00 (15.36%) | Buy | 87.35 |
| Evercore ISI Group | 01 Oct 2024 | 102.00 (22.57%) | Buy | 91.67 |
| Stifel | 30 Sep 2024 | 102.00 (22.57%) | Buy | 93.85 |
| UBS | 26 Sep 2024 | 74.00 (-11.08%) | Sell | 92.49 |
| BTIG | 18 Sep 2024 | 100.00 (20.16%) | Buy | 88.53 |
| JP Morgan | 09 Sep 2024 | 90.00 (8.15%) | Hold | 85.12 |
No data within this time range.
| TTM Dividend Yield | 0.14% |
| 1Y Average Dividend Yield | 0.12% |
| Payout Ratio | 3.29% |
| Expected Next Dividend Payment | May 2025 |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 14 Jan 2025 | 21 Nov 2024 | 14 Feb 2025 | 0.035 Cash |
| 18 Oct 2024 | 18 Sep 2024 | 15 Nov 2024 | 0.03 Cash |
| 19 Jul 2024 | 26 Jun 2024 | 15 Aug 2024 | 0.03 Cash |
| 18 Apr 2024 | 22 Mar 2024 | 15 May 2024 | 0.03 Cash |
| 12 Jan 2024 | 08 Dec 2023 | 15 Feb 2024 | 0.03 Cash |
| 19 Oct 2023 | 22 Sep 2023 | 15 Nov 2023 | 0.03 Cash |
| 20 Jul 2023 | 23 Jun 2023 | 15 Aug 2023 | 0.03 Cash |
| 22 May 2023 | 25 Apr 2023 | 15 Jun 2023 | 0.03 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2024 | 0.120 | 4 | 0.14 |
| 2023 | 0.090 | 3 | 0.12 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |